Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BAD
REST API REST API
Homo sapiens
BAD is differentially expressed in 265 experiments: 104 organism parts: prostate, bone marrow, ... (102 more);, 179 disease states: normal, control, ... (177 more);, 73 cell types 305 cell lines 43 compound treatments and 67 other conditions.
Synonyms BBC2, BCL2L8
Orthologs bad (Danio rerio)   BAD (Bos taurus)   Bad (Mus musculus)   BAD (2 of 2) (Danio rerio)   Bad (Rattus norvegicus)   LOC100487418 (Xenopus laevis)   Q45KI9_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, positive regulation of caspase activity, protein binding, apoptosis, cytokine-mediated signaling pathway, cytoplasm, cell proliferation, membrane, lipid binding, activation of caspase activity, phospholipid binding, positive regulation of apoptosis, ATP metabolic process, glucose homeostasis, fibroblast growth factor receptor signaling pathway, mitochondrial outer membrane, induction of apoptosis, protein kinase binding, protein heterodimerization activity, caspase activator activity, mitochondrion, regulation of apoptosis, positive regulation of B cell differentiation, activation of pro-apoptotic gene products, pore complex assembly, cellular response to mechanical stimulus, cellular response to hypoxia, induction of apoptosis by intracellular signals, positive regulation of insulin secretion, positive regulation of epithelial cell proliferation, induction of apoptosis by extracellular signals, positive regulation of T cell differentiation, positive regulation of glucokinase activity, nerve growth factor receptor signaling pathway, protein phosphatase binding, glucose catabolic process, regulation of mitochondrial membrane permeability, phosphatidylinositol-mediated signaling, cellular process regulating host cell cycle in response to virus, positive regulation of type B pancreatic cell development, type B pancreatic cell proliferation, cellular response to lipid, ADP metabolic process, positive regulation of mitochondrial membrane potential, positive regulation of insulin secretion involved in cellular response to glucose stimulus, cellular response to nicotine, regulation of cysteine-type endopeptidase activity involved in apoptotic process
UniProt Accession Q92934, Q6FH21, A8MXU7, F5GY71, F5GYS3, F5H1R6, F5H3B1
InterPro Term Bcl-2_BAD
Search EB-eye ENSG00000002330
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-MEXP-1251, E-GEOD-7224, ... (24 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, ... (38 experiments)

Factor Value U/D Experiments
HL-60
3
E-GEOD-5258, E-MTAB-37, E-GEOD-24147
MCF-7
3
E-GEOD-3529, E-GEOD-20081, E-GEOD-19639
BT-474
2
E-GEOD-5823, E-GEOD-3529
BT474
2
E-MTAB-37, E-MEXP-440
MOLT4
2
E-MTAB-62, E-MTAB-37
PC3
2
E-GEOD-5258, E-MEXP-2034
299 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-GEOD-19397, E-GEOD-3920, E-GEOD-360, ... (36 experiments)

Factor Value U/D Experiments
CD8+ T cell
2
E-MTAB-25, E-AFMX-5
embryonic stem cell
2
E-MEXP-930, E-GEOD-2248
fibroblast
2
E-GEOD-3920, E-GEOD-26672
testis - leydig cell
1
E-AFMX-5
B lymphocyte
1
1
E-GEOD-6691
CD34+
1
E-AFMX-5
67 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-MEXP-2069, E-GEOD-2549, E-TABM-15, ... (48 experiments)

Factor Value U/D Experiments
prostate carcinoma
3
E-MEXP-2034, E-MTAB-62, E-MTAB-37
uterine fibroid
2
E-GEOD-7307, E-MTAB-62
breast carcinoma
2
E-MTAB-37, E-TABM-276
acute quadriplegic myopathy
2
E-GEOD-3307, E-MTAB-62
lung adenocarcinoma
2
E-MTAB-62, E-MTAB-37
rhabdomyosarcoma
2
E-MTAB-62, E-MTAB-37
173 more value(s).


Compound treatment

studied in E-GEOD-7400, E-TABM-782, E-GEOD-3720, E-GEOD-5824, E-MEXP-2590, ... (27 experiments)

Factor Value U/D Experiments
none
2
7
E-GEOD-20719, E-TABM-782, E-GEOD-5824, E-GEOD-4600, E-GEOD-7400, ... (9 experiments)
glutamine
2
E-MEXP-1335, E-MEXP-941
TNF
1
E-GEOD-15205
ponasterone A
1
E-GEOD-3113
5-aza-2'-deoxycytidine + trichostatin A
2
1
E-MEXP-1269
chloroguine
1
E-GEOD-5418
37 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-GEOD-14359, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd3
studied in E-GEOD-22601

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-22513, E-MEXP-1251, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359, E-GEOD-6236, E-GEOD-4667, E-MTAB-62 ... (5 experiments)

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-3325, E-GEOD-21138, E-GEOD-3013 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MEXP-1482, E-GEOD-7578, E-MTAB-108, E-GEOD-6431, E-MEXP-2340, ... (6 experiments)

Genotype
studied in E-MEXP-421, E-GEOD-22593, E-TABM-868, E-TABM-601, E-MEXP-1838, ... (7 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-5681, E-GEOD-7011, E-GEOD-12773, ... (10 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-16194, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-1926, E-MEXP-2069, E-TABM-26, ... (33 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-MEXP-561, E-GEOD-17400

Injury
studied in E-GEOD-19743

Irradiate
studied in E-MEXP-2177

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-426, E-TABM-84

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-22152, E-GEOD-21750, E-GEOD-6434, E-GEOD-4600 ... (5 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19445, ... (6 experiments)

Replicate
studied in E-GEOD-10797

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-MEXP-548, E-GEOD-3697, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-21374, E-GEOD-17400, E-GEOD-18995

Sex
studied in E-GEOD-2466, E-GEOD-22541, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-TABM-276

Tissue
studied in E-GEOD-30573

Transfection
studied in E-GEOD-14680

Treatment
studied in E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-15799, ... (6 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271

Vehicle
studied in E-GEOD-5258

Processing time: 0.345 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM